Skip to main content
HIMS logo

Hims & Hers Health, Inc.

HIMSNYSEHealthcareDrug Manufacturers - Specialty & Generic

$27.59Today:- (-)1Y −39.93%

As of Oct 26, 2026 close

Market cap
$6.39B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$13.74$51.36
Volume (live)
-
Avg. volume (3M)
9.84M

Hims & Hers Health, Inc. (HIMS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Hims & Hers Health, Inc. stock.

Analyst Consensus Rating

Investment consensus from 16 professional research analysts

Consensus Rating

Hold
Based on 16 unique analysts
(20 total ratings in last 90 days)
High Confidence∞:1 Buy/Sell

Average Price Target

$32.82
+18.96% upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest HIMS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Allen Lutz
BofA Securities
HoldMaintains
$32.00
Allen Lutz
BofA Securities
HoldMaintains
$32.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Allen Lutz
BofA Securities
HoldReiterates
$32.00
Zacks Equity Research
Zacks Equity Research
HoldInitiates Coverage
-
Jailendra Singh
Truist
HoldReiterates
$32.00
Bryan Smilek
JP Morgan
HoldInitiates
$32.00
Brian Tanquilut
Jefferies
HoldMaintains
$31.00
Justin Patterson
KeyBanc
HoldMaintains
-
Indrajit Bandyopadhyay
Zacks Equity Research
HoldInitiates Coverage
-
Glen Santangelo
Barclays
BuyReiterates
$39.00 → $35.00
Glen Santangelo
Barclays
BuyReiterates
$39.00 → $35.00
Daniel Grosslight
Citi
HoldMaintains
$35.00 → $33.00
Maria Ripps
Canaccord Genuity
BuyReiterates
$40.00
David Larsen
BTIG
HoldInitiates Coverage
-
George Hill
Deutsche Bank
HoldReiterates
$25.00 → $26.00
Jonna Kim
TD Cowen
HoldReiterates
$25.00 → $30.00
Ryan MacDonald
Needham
BuyReiterates
$35.00 → $42.00
Mark Mahaney
Evercore ISI Group
HoldMaintains
-
Craig Hettenbach
Morgan Stanley
HoldInitiates Coverage
$21.00 → $28.00

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 16, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for HIMS?

The analyst consensus rating for HIMS is Hold, based on the latest ratings from 16 analysts over the last 90 days.

What is the average price target for HIMS?

The average 12-month price target for HIMS is $32.82, representing an upside of 19.0% from the Oct 26, 2026 close of $27.59.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.